Anesthesia Intraoral Module (AIM)
The minimally invasive but complex NORA (Non-Operating Room Anesthesia) procedures are being performed on older patients with multiple comorbidities. It is time to move past the limitations of face masks.
AIM delivers oxygen and captures carbon dioxide for capnography in patients under sedation, per the safety guidelines of the American Society of Anesthesiologists (ASA).
How is AIM used?
AIM is placed between the top and bottom molars on either side. Oxygen and capnography tubings are connected to the oxygen outlet and the capnography monitor.
96% and Higher Oxygen Delivery
AIM delivers oxygen closer to the tracheal inlet achieving an FiO2 of 96% and higher. While face masks claim high oxygen delivery, they measure oxygen “around the face”. Exhaled air under the mask, in the oral cavity and nasal sinuses dilutes oxygen before it reaches the lungs.
During a side-by-side comparison by an FDA-approved, third-party lab, oxygen sensor at tracheal level captured 58% FiO2 with a commonly used oxygen mask, and a significantly higher 96% oxygen delivery with AIM.
Higher oxygen delivery ensures a favorable outcome in patients with low oxygen reserves (obesity, CHF, COPD, low EF or overly sedated, hypoventilating patients).
Improved Capnography
AIM captures pharyngeal CO2 with prominent capnography waveforms. The smaller waveforms of a hypoventilating patient (from upper airway obstruction, over-sedation) are easier to identify. An early alert can prevent a hypoxic event in remote hospital locations.
Oxygen flowing inside the face mask may wash out the CO2 resulting in artifacts and may not accurately reflect the breathing status of a sedated patient, when seconds count.
Single-Step Oral Airway Placement
Oral airway placement for upper airway obstruction is a multi-step process (remove face mask, pry the jaw open of a sedated, often uncooperative patient, place oral airway, replace face mask).
Full oral cavity access and uninterrupted oxygenation with AIM enables oral airway placement in a single-step, minimizing procedural interruptions.
Seamless Conversion to General Anesthesia
Emergent conversion to general anesthesia may become necessary (excessive patient movement, extreme pain, or respiratory failure).
With access to the oral cavity and ongoing pre-oxygenation, AIM replaces the often rushed and injury-prone maneuvers with a seamless conversion to general anesthesia, using a supraglottic device or endotracheal intubation.
Eliminates Bite-blocks
AIM eliminates the need for the endoscopy bite blocks and the pink airways for awake fiberoptic intubations, minimizing patient discomfort, reducing exposure to contaminated objects, and medical waste disposal.
May Lower the Risk of Airway Fires
Nasal cannulas and face masks accumulate oxygen around patient’s face (oxygen is heavier than air), risking airway fires, patient injuries and malpractice lawsuits.
AIM’s oxygen delivery into the oro-pharynx may help reduce the risk of airway fires.
Small Size, Big Impact
Despite its small size, 96% or higher oxygen delivery, reliable capnography, single-step airway resuscitation and seamless conversion to general anesthesia make AIM an ideal device for a broad range of sedation procedures.
Lower Environmental Impact
Due to it’s compact size, AIM consumes fewer manufacturing resources.
Additionally, by eliminating the need for EGD and TEE bite-blocks and awake fiberoptic intubation (pink) airways, AIM further lowers disposable consumption.
Manufactured in the USA
With a focus on manufacturing the highest quality medical device, everything from the device molds, sourcing raw materials, manufacturing, and packaging is done here in the US.
No overseas containers, and no supply chain issues.
